Delivery Order SPE2DB24D1205-SPE2DB25FCURG

Award Date 3/6/25
Potential Completion Date 3/27/25
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,287.20 firm fixed-price contract is for the supply of VYEPTI 100 MG/ML VIALML, a medication, with a performance period ending on February 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,628.72, is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of February 14, 2025. The award was made on January 24, 2025, and there is no set-aside designation indicated. AmerisourceBergen holds...
This is a delivery order awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,337.55 firm fixed-price contract is for the supply of VYEPTI 100 MG/ML VIAL, a specialty pharmaceutical product. The order has an ultimate completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The award does not have a set-aside designation. The potential value of the delivery order is $14,945.14, with a completion date of March 27, 2024. Amerisourcebergen Drug...
This contract award, valued at $5,785.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of VYEPTI 100 MG/ML vials, a prescription medication, with a completion date of January 28, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VYEPTI 100 MG/ML VIAL, a pharmaceutical product. The contract has a potential value of $4,270.04 and a completion date of March 12, 2024. Amerisourcebergen Drug Corp serves as the prime contractor for this delivery order, which is not associated with any set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $6,405.06 firm fixed price delivery order is for VYEPTI 100 MG/ML VIALML, a specialty pharmaceutical product. The contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
This federal contract award is for the delivery of VYEPTI 100 MG/ML VIALML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,471.54 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 14, 2025 and was awarded on February 21, 2025. There is no set-aside designation indicated for this contract. Amerisourcebergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $10,675.10, is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. It is a firm fixed-price contract with a completion date of September 27, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $16,012.65 fixed-price contract is for the supply of VYEPTI 100 MG/ML vials. AmerisourceBergen, a large pharmaceutical distributor, is a major supplier of medical products and medications to federal agencies through various Indefinite Delivery Contracts, including a $999,999,999 DLA contract and a $750,000 Department of Justice contract. This...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCURG
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,943.08, is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 27, 2025. The contract was awarded on March 6, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/5/25, 10:18 AM